Halozyme Therapeutics
HALO
#2629
Rank
$4.42 B
Marketcap
$33.57
Share price
3.32%
Change (1 day)
-24.48%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2022 : $1.50 B

According to Halozyme Therapeutics's latest financial reports the company's total debt is $1.50 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2012 to 2022)

Total debt by year

Year Total debt Change
2022-12-31$1.50 B71.8%
2021-12-31$0.87 B120.7%
2020-12-31$0.39 B-1.33%
2019-12-31$0.40 B218.55%
2018-12-31$0.12 B-37.54%
2017-12-31$0.20 B-6.59%
2016-12-31$0.21 B334.69%
2015-12-31$49.83 M-0.05%
2014-12-31$49.86 M0.18%
2013-12-31$49.77 M59.98%
2012-12-31$31.11 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$39.65 B 2,533.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$34.87 B 2,215.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.88 B 1,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.71 B 1,408.37%๐Ÿ‡ซ๐Ÿ‡ท France
$16.88 B 1,021.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38 B-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA